Another study where treatment with ONO-4817 significantly inhibited MMP-9 activity demonstrated attenuated left ventricular remodeling within one day after myocardial infarction, highlighting its potential therapeutic role in post-MI complications [47]. The gene discussed is MMP9; the disease is myocardial infarction.